Upregulated CD58 is associated with clinicopathological characteristics and poor prognosis of patients with pancreatic ductal adenocarcinoma

BACKGROUND: CD58 has been demonstrated to be abnormally expressed in multiple hematopoietic malignancies and solid tumors and plays an essential role in tumorigenesis and progression; however, its clinical significance and prognostic value in pancreatic ductal adenocarcinoma (PDAC) remain unknown. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yalu, Liu, Qiaofei, Liu, Jingkai, Liao, Quan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243423/
https://www.ncbi.nlm.nih.gov/pubmed/34193136
http://dx.doi.org/10.1186/s12935-021-02037-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243423/
https://www.ncbi.nlm.nih.gov/pubmed/34193136
http://dx.doi.org/10.1186/s12935-021-02037-0

Ejemplares similares